Aptorum Group Limited - Class A Ordinary Shares (APM): Price and Financial Metrics

Aptorum Group Limited - Class A Ordinary Shares (APM)

Today's Latest Price: $2.46 USD

0.13 (5.58%)

Updated Nov 27 12:59pm

Add APM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

APM Stock Summary

  • With a one year PEG ratio of 0.51, Aptorum Group Ltd is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 6.3% of US stocks.
  • Aptorum Group Ltd's stock had its IPO on December 18, 2018, making it an older stock than only 4.08% of US equities in our set.
  • APM's price/sales ratio is 126.41; that's higher than the P/S ratio of 97.37% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Aptorum Group Ltd are SENS, VSTM, SIGA, TTOO, and INSM.
  • APM's SEC filings can be seen here. And to visit Aptorum Group Ltd's official web site, go to www.aptorumgroup.com.

APM Stock Price Chart Interactive Chart >

Price chart for APM

APM Price/Volume Stats

Current price $2.46 52-week high $18.25
Prev. close $2.33 52-week low $1.16
Day low $2.37 Volume 267,784
Day high $2.49 Avg. volume 520,404
50-day MA $2.31 Dividend yield N/A
200-day MA $3.45 Market Cap 83.67M

Aptorum Group Limited - Class A Ordinary Shares (APM) Company Bio

Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

APM Latest News Stream

Event/Time News Detail
Loading, please wait...

APM Latest Social Stream

Loading social stream, please wait...

View Full APM Social Stream

Latest APM News From Around the Web

Below are the latest news stories about Aptorum Group Ltd that investors may wish to consider to help them evaluate APM as an investment opportunity.

Aptorum Group raises $9M in public offering

Aptorum Group (APM) has priced its public offering of 2,769,231 Class A ordinary shares and warrants to purchase up to same number of Class A shares, at a combined price of $3.25/share and related warrant, for expected gross proceeds of ~$9M.The five-year warrants have an exercise price of $3.25/share. Net...

Seeking Alpha | September 30, 2020

Aptorum Group Limited 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Aptorum Group Limited in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | September 2, 2020

Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM

Regulatory News:

Yahoo | July 24, 2020

Aptorum Group Prospectus Receives Approval for Listing on the Euronext Paris Stock Exchange

Regulatory News:

Yahoo | July 17, 2020

Here's What Aptorum Group Limited's (NASDAQ:APM) Shareholder Ownership Structure Looks Like

The big shareholder groups in Aptorum Group Limited (NASDAQ:APM) have power over the company. Generally speaking, as a...

Yahoo | July 3, 2020

Read More 'APM' Stories Here

APM Price Returns

1-mo 20.59%
3-mo 16.04%
6-mo -20.09%
1-year -84.11%
3-year N/A
5-year N/A
YTD -84.48%
2019 4.41%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0237 seconds.